Treatment of multi-vessel coronary artery disease. What is the optimal revascularisation approach? What do we know, what will we learn?

Hellenic Journal of Cardiology

Volumn 48, Issue 1, 2007, Pages 1-4

  Vaina, Sophia ^a   Stefanadis, Christodoulos ^a,b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Coronary artery bypass grafting; Multi vessel disease; Stent implantation

Indexed keywords

ANTITHROMBOCYTIC AGENT;

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; EDITORIAL; FOLLOW UP; HUMAN; IMPLANTATION; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SCORING SYSTEM; STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART MUSCLE REVASCULARIZATION; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 34247646978     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Morrison DA, Sethi G, Sacks J, et al: Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 2001; 38: 143-149.
2. Rodriguez A, Bernardi V, Navia J, et al: Argentine Randomized Study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001; 37: 51-58.
3. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993; 341: 573-580.
4. CABRI Trial Participants: First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995; 346: 1179-1184.
5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-225.
6. Rodriguez AE, Baldi J, Fernandez Pereira C, et al: Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005; 46: 582-588.
7. The SoS Investigators: Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002; 360: 965-970.
8. Serruys PW, Unger F, van Hout BA, et al: The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol 1999; 4: 209-219.
9. Serruys PW, Unger F, Sousa JE, et al: Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124.
10. Serruys PW, Ong AT, van Herwerden LA, et al: Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
11. Mercado N, Wijns W, Serruys PW, et al: One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005; 130: 512-519.
12. Chieffo A, Stankovic G, Bonizzoni E, et al: Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005; 111: 791-795.
13. Ong AT, Serruys PW, Aoki J, et al: The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 2005; 45: 1135-1141.
14. Daemen J, Ong AT, Stefanini GG, et al: Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol 2006; 98: 895-901.
15. Korovesis S, Karvouni E, Giazitzoglou E, et al: Drug-eluting stents: immediate and long-term results. Hellenic J Cardiol 2005; 46: 330-335.
16. Iakovou I, Schmidt T, Bonizzoni E, et al: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
17. McFadden EP, Stabile E, Regar E, et al: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
18. Ong AT, McFadden EP, Regar E, et al: Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
19. Ong AT, Hoye A, Aoki J, et al: Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-953.
20. Iakovou I, Mehran R, Dangas G: Thrombosis after implantation of drug-eluting stents. Hellenic J Cardiol 2006; 47: 31-38.
21. Sionis DG, Iakovou IT: Cost-effectiveness of drug-eluting stents. Hellenic J Cardiol 2006; 47: 292-297.
22. Serruys P, Ong AT, Morice MC, et al: Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2005; 2: 147-156.
23. Ong AT, Serruys PW, Mohr FW, et al: The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006; 151: 1194-1204.
24. Sianos G, Morel MA, Kappetein AP, et al: The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 2: 219-227.
25. Kapur A, Malik IS, Bagger JP, et al: The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Am Heart J 2005; 149: 13-19.
26. Kappetein AP, Dawkins K, Mohr FW, et al: Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease: Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006; 29: 486-491.